| Description | ot-730（QLT 091568） is a new selective beta blocker prodrug that can be used to study eye diseases. |
| Synonyms | QLT 091568 |
| molecular weight | 492.56 |
| Molecular formula | C25H36N2O8 |
| CAS | 870809-51-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Townsend W. Ophthalmic drugs: optometry's liquid gold: the ophthalmic drug pipeline is rich with emerging pharmaceuticals that may one day change the way you treat ocular diseases, such as glaucoma, dry eye and macular disease. What's more, innovative new treatments also could help stop cataract formation in its tracks[J]. Review of Optometry, 2006, 143(6): 54-60. |